title: [Disorders of blood rheology in Walker's carcinosarcoma-256 and in cyclophosphamide treatment of rats].
abstract: Tumor process development in rats inoculated with cellular suspension of transplantable Walker's carcinosarcoma-256 involved enhanced thickening of blood on day 7. Treatment with 20 mg/kg cyclophosphamide, thrice a day, every other day, retarded tumor process and brought hemorheologic indices further down, at the same time. Similar treatment of intact rats with cyclophosphamide caused hemorheologic disorders too.
authors.affiliation: Research Institute of Pharmacology, Russian Academy of Medical Sciences, Siberian Branch, Tomsk.
authors.forename: M B
authors.initials: MB
authors.lastname: Plotnikov
authors.forename: M Iu
authors.initials: MIu
authors.lastname: Maslov
authors.forename: O I
authors.initials: OI
authors.lastname: Aliev
authors.forename: A S
authors.initials: AS
authors.lastname: Vasil'ev
authors.forename: E P
authors.initials: EP
authors.lastname: Zueva
authors.forename: S G
authors.initials: SG
authors.lastname: Krylova
authors.forename: N V
authors.initials: NV
authors.lastname: Shilova
mesh_terms: D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D002279:Carcinoma 256, Walker / Q000097:blood* / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D018056:Hemorheology / Q000187:drug effects*; D008297:Male; D051381:Rats; D017208:Rats, Wistar
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003520:Cyclophosphamide